Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Air Liquide Confirms Preliminary Discussions about Possible Sale of Aqua Lung

Air Liquide Confirms Preliminary Discussions about Possible Sale of Aqua Lung

Regulatory News:

Air Liquide (Paris:AI), which regularly reviews its business portfolio, confirms that it is evaluating the opportunity to potentially divest Aqua Lung, a major player in personal aquatic equipment for recreational and professional use, in order to best support Aqua Lung’s next phase of growth and enable it to deliver on its strategic roadmap. Air Liquide is focused on its Gas & Services activities following the Group’s acquisition of Airgas, as well as on the implementation of its company program NEOS for the 2016-2020 period.

There can be no assurances that any of these discussions will result in an agreement or that a transaction will be completed. The Group has no further information to share at this time.

About Aqua Lung
Present in around 90 countries with approximately 1,000 employees, Air Liquide subsidiary Aqua Lung is a major player in personal aquatic equipment for recreational and professional use. Founded in 1946, Aqua Lung is a historical expert in SCUBA diving and has expanded its offering to complementary areas such as swimming, aqua fitness and free diving. In 2015, Aqua Lung generated approximately €200 million in revenue.

---

The world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with approximately 68,000 employees and serves more than 3 million customers and patients*. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the company’s activities since its creation in 1902.

Air Liquide’s ambition is to lead its industry, deliver long-term performance and contribute to sustainability. The company’s customer-centric transformation strategy aims at profitable growth over the long term. It relies on operational excellence, selective investments, open innovation and a network organization implemented by the Group worldwide. Through the commitment and inventiveness of its people, Air Liquide leverages energy and environment transition, changes in healthcare and digitization, and delivers greater value to all its stakeholders.

Air Liquide’s revenues amounted to €16.4 billion in 2015, and its solutions that protect life and the environment represented more than 40% of sales. On 23 May 2016, Air Liquide completed its acquisition of Airgas, which had revenues amounting to $5.3 billion (around €4.8 billion) for the fiscal year ending 31 March 2016.

Air Liquide is listed on the Paris Euronext stock exchange (compartment A) and belongs to the CAC 40 and Dow Jones Euro Stoxx 50 indexes.

* Following the acquisition of Airgas on 23 May 2016

www.airliquide.com
Follow us on Twitter @airliquidegroup

Air Liquide
Corporate Communications
Caroline Philips, +33 (0)1 40 62 50 84
or
Aurélie Wayser-Langevin, +33 (0)1 40 62 56 19
or
Caroline Brugier, +33 (0)1 40 62 50 59
or
Investor Relations
Paris
+33 (0)1 40 62 50 87
or
Radnor
+1 (0) 610 263 8277



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today